Related Experiment Video

Updated: Mar 19, 2026

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
08:04

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

13.4K

PTHrP, its receptor, and protein kinase A activation in osteosarcoma

Carl R Walkley1, Mannu K Walia1, Patricia W Ho1

  • 1St. Vincent's Institute of Medical Research and Department of Medicine; St. Vincent's Hospital; University of Melbourne ; Fitzroy, VIC, Australia.

Molecular & Cellular Oncology
|June 17, 2016
PubMed

Insights

Knocking down the parathyroid hormone-related protein (PTHrP) receptor in osteosarcoma hinders cyclic AMP-dependent protein kinase A (PKA) activation. This significantly reduces tumor differentiation, invasion, and proliferation, highlighting PKA

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Osteosarcoma is a primary bone cancer with complex pathogenesis.
  • The parathyroid hormone-related protein (PTHrP) receptor is implicated in various cellular processes.
  • Cyclic AMP-dependent protein kinase A (PKA) is a key signaling molecule in cellular regulation.

Purpose of the Study:

  • To investigate the role of the PTHrP receptor in osteosarcoma.
  • To determine the impact of modulating PTHrP receptor activity on PKA signaling.
  • To assess the effect of these changes on tumor progression in vivo.

Main Methods:

  • Osteosarcoma cell models were utilized.
  • Knockdown of the PTHrP receptor was performed.
  • Activation of the PKA pathway was measured.
  • Tumor differentiation, invasion, and proliferation were assessed in vivo.

Main Results:

  • Downregulation of the PTHrP receptor significantly reduced PKA pathway activation.
  • Tumor differentiation was substantially decreased following PTHrP receptor knockdown.
  • Invasion and proliferation of osteosarcoma cells were significantly inhibited in vivo.

Conclusions:

  • The PTHrP receptor plays a critical role in osteosarcoma pathogenesis.
  • Modulating the PTHrP receptor impacts PKA signaling, affecting tumor aggressiveness.
  • Targeting the PKA pathway presents a potential therapeutic strategy for osteosarcoma.
Keywords:
PKAPTHR1PTHrPosteosarcoma

More Related Videos

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

4.4K
A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

14.9K

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
20.4K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
88.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.8K